While AFP-L3+/DCP+ expressing patients were more likely to have larger index size (2.8 cm vs 3.8 cm), the cumulative tumor burden and LDT approach were similar between phenotypes suggesting a similar clinical approach to treatment. This evidence concerns the gene AFP and neoplasm.